|
Invited Speakers:
|
|
Johan DE BAERE
Global Head of Outsourcing and Contracts, UCB PharmaMarc de LONGUEVILLE
M.D.,UCL, FFPM , MBCPM, Development Therapeutic Group Allergy and Asthma, UCB Pharma Viviane De MAERTELAER
Ph.D. in physics, ULB, Professor at the ULB Christian de MEY
M.D., FFPM, FRCP, Associat. Prof. University of Frankfurt, Clinical pharmacologist ACPS, Mainz-Kastel, Germany Marie-Paule DERDE
Ph.D. in pharmaceutical Sciences, General Manager, Data Investigation Company Europe (DICE), Brussels Stéphane DEWIT
M.D., Ph.D., ULB-AIDS Reference Centre CHU Saint-Pierre, Brussels Yves GEYSELS
Ph.D., Head Clinical Research Operations Europe North, Novartis Past Chair of the Association of Clinical Research Professionals (ACRP), Ass. Prof. at the University College of Antwerp, Dept. of Healthcare André HERCHUELZ
M.D., Ph.D., Professor of Pharmacology at the ULB, Member of the Belgian Medicines Commission, Chairman of the Ethics Committee of Erasme Hospital Denis LACOMBE
M.D., M.Sc., European Organisation for Research and Treatment of Cancer (EORTC), Brussels Christian MELOT
M.D., Ph.D., ULB, M. Sci. Biostatistics, Limburgs Universitair Centrum, Professor of Biostatistics at ULB, Associate Professor at the Intensive Care Department, Erasme Hospital Françoise MEUNIER
M.D., Ph.D., ULB, FRCP, FFPM, General Director of the European Organisation for Research and Treatment of Cancer (EORTC), Brussels Monique PODOOR
M.D., Dip. Pharm. Med., Head of PHARMAKON, Luxembourg Eckart W. SCHWARZ
M.B., Ch.B., University of Bristol, Vice President & Global Head, New Product Development, GSK Biologicals, Rixensart, Belgium Jean-Pierre TASSIGNON
M.D., ULB, FFPM, Dipl. Pharm. Med., Executive Vice-President, PSI Pharma Support, Inc.
Susan TRAINOR
Diploma in Nursing Montreal, Canada, President and COO of Trainor & Partners International Roger VERBEECK
Ph.D. in pharmacy, KUL, Professor, School of pharmacy, UCL Dominique VERHOEVEN
M.Sc., Director Project Management Europe, Pharmaceutical Product Development (PPD), Brussels Georges WEISSBERGER
M.D., Medical Director, Pfizer Phase I Unit, Brussels
|
|